Silexion Therapeutics Corp [NASDAQ: SLXN] closed the trading session at $0.91 on 2025-07-09. The day’s price range saw the stock hit a low of $0.8391, while the highest price level was $0.99.
The stocks have a year to date performance of -99.11 percent and weekly performance of 13.41 percent. The stock has been moved at -57.68 percent over the last six months. The stock has performed -3.80 percent around the most recent 30 days and changed 19.72 percent over the most recent 3-months.
If compared to the average trading volume of 1.64M shares, SLXN reached to a volume of 11159821 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Silexion Therapeutics Corp [SLXN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SLXN shares is $5.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SLXN stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 3.06, with the Price to Cash per share for the same quarter was set at 0.71.
SLXN stock trade performance evaluation
Silexion Therapeutics Corp [SLXN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 13.41. With this latest performance, SLXN shares dropped by -3.80% in over the last four-week period, additionally sinking by -57.68% over the last 6 months – not to mention a drop of -54.73% in the past year of trading.
Silexion Therapeutics Corp [SLXN]: An insightful look at the core fundamentals
Return on Equity for this stock declined to -218.41%, with Return on Assets sitting at -218.41%.
Earnings per share (EPS) analysis for Silexion Therapeutics Corp [SLXN] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SLXN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Silexion Therapeutics Corp go to 63.05%.
Silexion Therapeutics Corp [SLXN]: Institutional Ownership
There are presently around $10.41%, or 11.08% of SLXN stock, in the hands of institutional investors.
